Cangene (FRA:YGE) Dividend Payout Ratio : 0.00 (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Dividend Payout Ratio?

Cangene's dividend payout ratio for the months ended in Oct. 2013 was 0.00.

The historical rank and industry rank for Cangene's Dividend Payout Ratio or its related term are showing as below:

FRA:YGE's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-16), the Dividend Yield % of Cangene is 0.00%.

Cangene's Dividends per Share for the months ended in Oct. 2013 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Cangene Dividend Payout Ratio Historical Data

The historical data trend for Cangene's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Dividend Payout Ratio Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Dividend Payout Ratio

Get a 7-Day Free Trial

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cangene's Dividend Payout Ratio

For the Biotechnology subindustry, Cangene's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cangene's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Cangene's Dividend Payout Ratio falls into.

Cangene Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Cangene's Dividend Payout Ratio for the fiscal year that ended in Jul. 2013 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jul. 2013 )	/	EPS without NRI (A: Jul. 2013 )
	=	0	/	0.015
	=	0.00

Cangene's Dividend Payout Ratio for the quarter that ended in Oct. 2013 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Oct. 2013 )	/	EPS without NRI (Q: Oct. 2013 )
	=	0	/	-0.059
	=	N/A

Cangene (FRA:YGE) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Cangene Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Cangene's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines